Ukrain (NSC-631570) in experimental and clinical studies: A review

Drugs under Experimental and Clinical Research

Volumn 24, Issue 5-6, 1998, Pages 213-219

  Jagiello Wojtowicz E ^a   Kleinrok, Z ^a   Urbanska, E M ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

NSC 631570; UKRAIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL METABOLISM; CYTOSTASIS; DNA SYNTHESIS INHIBITION; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; DRUG UPTAKE; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LD 50; NONHUMAN; OXYGEN CONSUMPTION; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BERBERINE ALKALOIDS; CLINICAL TRIALS; HUMANS; NEOPLASMS; PHENANTHRIDINES;

EID: 0032467749     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Danilos J., Zbroja-Sontag W., Baran E., Kurylcio L., Kondratowicz L., Jusiak L. Preliminary studies on the effect of Ukrain(Tris{2-{[5bS-(5ba,6b,12ba)]-5b, 6, 7, 12b, 13, 14-hexahydro-13-methyl[1,3]benzodioxolo[5,6-c-]-1,3-dioxolo[4,5-i] phenathridinium-6-ol]-ethaneaminy}phosphine-sulfide 6HCl) on the immunological response in patients with malignant tumors. Drugs Exptl. Clin. Res. XVIII (Suppl.), 55, 1992.
2. Liepins A., Nowicky J.W. Selective induction of programmed cell death (apoptosis) in malignant cells by the alkaloid derivative Ukrain (NSC 631570). 11th Future Trends in Chemotherapy, Interdisciplinary World Congress on Antimicrobial and Anticancer Drugs, 25-27 April 1994, Geneva, Switzerland, Abstr. 93.
3. Liepins A., Nowicky J.W. Modulation of immune effector cell cytolytic activity and tumor growth inhibition in vivo by Ukrain (NSC 631570). Drugs Exptl. Clin. Res., XXII (Suppl.), 31, 1996.
4. Nowicky J.W., Liepins A., Staniszewski A., Slesak B., Nowicky W., Hiesmayr W. The malignotoxic and immune modulating properties of the alkaloid derivative Ukrain. J. Cancer Res. Clin. Oncol., 118 (Suppl.), VI.09.05, 1992.
5. Nowicky J.W., Nowicky W., Liepins A. Cytostatic and cytotoxic effects of Ukrain on malignant cells. J. Chemother., 5 (Suppl. 1), 797, 1993.
6. Staniszewski A., Slezak B., Kolodziej J., Harlozinska-Szmyrka A. Lymphocytes subsets in patients with lung cancer treated with thiophosphoric acid alkaloid derivatives from Chelidonium majus L (Ukrain). Drugs Exptl. Clin. Res., XVIII (Suppl.), 63, 1992.
7. Nowicky J.W., Markowska J., Brzosko W.J. Ukrain and natural killer cells. Recent Advances in Chemotherapy, Proc. 18th Int. Cong. Chemother., Stockholm, Sweden, 1993.
8. Lohninger A., Hamler F. Chelidonium majus L. (Ukrain) in the treatment of cancer patients. Drugs Exptl. Clin. Res., XVIII (Suppl.), 73, 1992.
9. Lohninger A., Musanowyc J., Judmaier F., et al. Results of phase II clinical studies with Ukrain. Recent Advances in Chemotherapy, Proc. 18th Int. Cong. Chemother., Stockholm, Sweden, 1993.
10. Musianowycz J., Judmajer F., Manfreda D., et al. Clinical studies of Ukrain in terminal cancer patients (phase II). Drugs Exptl. Clin. Res., XVIII (Suppl.), 45, 1992.
11. Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J., Lohninger A. Ukrain both as an anticancer and immunoregulatory agent. Drugs Exptl. Clin. Res., XVIII (Suppl.), 17, 1992.
12. Nowicky J.W., Manolakis G., Meijer D., Vatanasapt V., Brzosko W.J., Lohninger A. Immunological and tumoricidal properties of Ukrain. Recent Advances in Chemotherapy, Proc. 18th Int. Cong. Chemother., Stockholm, Sweden, 1993.
13. Pengsaa P., Wongpratoom W., Vatanasapt V., et al. The effects of alkaloid thiophosphoric acid derivative (Ukrain) on cervical cancer, stage IB bulky. Drugs Exptl. Clin. Res., XVIII (Suppl.), 69, 1992.